Artificial Intelligence (AI) in Drug Discovery Market by Offering, By Technology, By Application, By End User and By Region – Global Opportunities & Forecast, 2020-2027
Artificial Intelligence (AI) in Drug Discovery Market by Offering (Software and Services), By Technology (Machine Learning and Other Technologies), By Application (Neurodegenerative Diseases, Immuno-oncology, Cardiovascular Disease, Metabolic Diseases and Other Applications), By End User and By Region – Global Opportunities & Forecast, 2020-2027
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Artificial Intelligence (AI) in Drug Discovery Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Artificial Intelligence (AI) in Drug Discovery Market Revenue Forecast till 2027
5. Global Artificial Intelligence (AI) in Drug Discovery Market by Offering Revenue Forecast till 2027
5.1. Software
5.2. Services
6. Global Artificial Intelligence (AI) in Drug Discovery Market by Technology Revenue Forecast till 2027
6.1. Machine Learning
6.1.1. Deep Learning
6.1.2. Supervised Learning
6.1.3. Reinforcement Learning
6.1.4. Unsupervised Learning
6.1.5. Other Machine Learning Technologies
6.2. Other Technologies
7. Global Artificial Intelligence (AI) in Drug Discovery Market by Application Revenue Forecast till 2027
7.1. Immuno-oncology
7.2. Neurodegenerative Diseases
7.3. Cardiovascular Diseases
7.4. Metabolic Diseases
7.5. Other Applications
8. Global Artificial Intelligence (AI) in Drug Discovery Market by End User Revenue Forecast till 2027
8.1. Pharmaceutical & Biotechnology Companies
8.2. Contract Research Organizations
8.3. Research Centers and Academic & Government Institutes
9. Global Artificial Intelligence (AI) in Drug Discovery Market by Region Forecast till 2027
9.1. North America Artificial Intelligence (AI) in Drug Discovery Market Revenue Forecast till 2027
(Option 1: As a part of the free 25% customization)
9.1.1. North America Artificial Intelligence (AI) in Drug Discovery Market by Offering
9.1.1.1. Software
9.1.1.2. Services
9.1.2. North America Artificial Intelligence (AI) in Drug Discovery Market by Technology
9.1.2.1. Machine Learning
9.1.2.1.1. Deep Learning
9.1.2.1.2. Supervised Learning
9.1.2.1.3. Reinforcement Learning
9.1.2.1.4. Unsupervised Learning
9.1.2.1.5. Other Machine Learning Technologies
9.1.2.2. Other Technologies
9.1.3. North America Artificial Intelligence (AI) in Drug Discovery Market by Application
9.1.3.1. Immuno-oncology
9.1.3.2. Neurodegenerative Diseases
9.1.3.3. Cardiovascular Diseases
9.1.3.4. Metabolic Diseases
9.1.3.5. Other Applications
9.1.4. North America Artificial Intelligence (AI) in Drug Discovery Market by End User
9.1.4.1. Pharmaceutical & Biotechnology Companies
9.1.4.2. Contract Research Organizations
9.1.4.3. Research Centers and Academic & Government Institutes
9.1.5. US Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.1.6. Canada Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.2. Europe Artificial Intelligence (AI) in Drug Discovery Market Revenue Forecast till 2027
(Option 2: As a part of the free 25% customization)
9.2.1. Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering
9.2.1.1. Software
9.2.1.2. Services
9.2.2. Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology
9.2.2.1. Machine Learning
9.2.2.1.1. Deep Learning
9.2.2.1.2. Supervised Learning
9.2.2.1.3. Reinforcement Learning
9.2.2.1.4. Unsupervised Learning
9.2.2.1.5. Other Machine Learning Technologies
9.2.2.2. Other Technologies
9.2.3. Europe Artificial Intelligence (AI) in Drug Discovery Market by Application
9.2.3.1. Immuno-oncology
9.2.3.2. Neurodegenerative Diseases
9.2.3.3. Cardiovascular Diseases
9.2.3.4. Metabolic Diseases
9.2.3.5. Other Applications
9.2.4. Europe Artificial Intelligence (AI) in Drug Discovery Market by End User
9.2.4.1. Pharmaceutical & Biotechnology Companies
9.2.4.2. Contract Research Organizations
9.2.4.3. Research Centers and Academic & Government Institutes
9.2.5. UK Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.2.6. Germany Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.2.7. France Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.2.8. Spain Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.2.9. Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.3. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Revenue Forecast till 2027
(Option 3: As a part of the free 25% customization)
9.3.1. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering
9.3.1.1. Software
9.3.1.2. Services
9.3.2. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology
9.3.2.1. Machine Learning
9.3.2.1.1. Deep Learning
9.3.2.1.2. Supervised Learning
9.3.2.1.3. Reinforcement Learning
9.3.2.1.4. Unsupervised Learning
9.3.2.1.5. Other Machine Learning Technologies
9.3.2.2. Other Technologies
9.3.3. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Application
9.3.3.1. Immuno-oncology
9.3.3.2. Neurodegenerative Diseases
9.3.3.3. Cardiovascular Diseases
9.3.3.4. Metabolic Diseases
9.3.3.5. Other Applications
9.3.4. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by End User
9.3.4.1. Pharmaceutical & Biotechnology Companies
9.3.4.2. Contract Research Organizations
9.3.4.3. Research Centers and Academic & Government Institutes
9.3.5. China Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.3.6. India Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.3.7. Japan Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.3.8. Rest of APAC Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.4. RoW Artificial Intelligence (AI) in Drug Discovery Market Revenue Forecast till 2027
(Option 4: As a part of the free 25% customization)
9.4.1. RoW Artificial Intelligence (AI) in Drug Discovery Market by Offering
9.4.1.1. Software
9.4.1.2. Services
9.4.2. RoW Artificial Intelligence (AI) in Drug Discovery Market by Technology
9.4.2.1. Machine Learning
9.4.2.1.1. Deep Learning
9.4.2.1.2. Supervised Learning
9.4.2.1.3. Reinforcement Learning
9.4.2.1.4. Unsupervised Learning
9.4.2.1.5. Other Machine Learning Technologies
9.4.2.2. Other Technologies
9.4.3. RoW Artificial Intelligence (AI) in Drug Discovery Market by Application
9.4.3.1. Immuno-oncology
9.4.3.2. Neurodegenerative Diseases
9.4.3.3. Cardiovascular Diseases
9.4.3.4. Metabolic Diseases
9.4.3.5. Other Applications
9.4.4. RoW Artificial Intelligence (AI) in Drug Discovery Market by End User
9.4.4.1. Pharmaceutical & Biotechnology Companies
9.4.4.2. Contract Research Organizations
9.4.4.3. Research Centers and Academic & Government Institutes
9.4.5. Brazil Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.4.6. South Africa Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.4.7. Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.4.8. UAE Artificial Intelligence (AI) in Drug Discovery Market All-Up
9.4.9. Rest of world (remaining countries of the LAMEA region) Artificial Intelligence (AI) in Drug Discovery Market All-Up
10. Competitive Landscape Analysis
10.1. Porter’s Five Forces Analysis
10.2. Industry – Competitive Landscape
10.3. Market Presence (Intensity Mapping)
10.4. Key Strategic Market Developments
11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
11.1. Microsoft Corporation
11.1.1. Company Overview
11.1.2. Key Executives
11.1.3. Footprint & Employee Strength
11.1.4. Product Offerings
11.1.5. Financials
11.1.6. Key Company Developments
11.2. NVIDIA Corporation
11.2.1. Company Overview
11.2.2. Key Executives
11.2.3. Footprint & Employee Strength
11.2.4. Product Offerings
11.2.5. Financials
11.2.6. Key Company Developments
11.3. IBM Corporation
11.3.1. Company Overview
11.3.2. Key Executives
11.3.3. Footprint & Employee Strength
11.3.4. Product Offerings
11.3.5. Financials
11.3.6. Key Company Developments
11.4. Google
11.4.1. Company Overview
11.4.2. Key Executives
11.4.3. Footprint & Employee Strength
11.4.4. Product Offerings
11.4.5. Financials
11.4.6. Key Company Developments
11.5. Atomwise, Inc.
11.5.1. Company Overview
11.5.2. Key Executives
11.5.3. Footprint & Employee Strength
11.5.4. Product Offerings
11.5.5. Financials
11.5.6. Key Company Developments
11.6. Deep Genomics
11.6.1. Company Overview
11.6.2. Key Executives
11.6.3. Footprint & Employee Strength
11.6.4. Product Offerings
11.6.5. Financials
11.6.6. Key Company Developments
11.7. Cloud Pharmaceuticals, Inc.
11.7.1. Company Overview
11.7.2. Key Executives
11.7.3. Footprint & Employee Strength
11.7.4. Product Offerings
11.7.5. Financials
11.7.6. Key Company Developments
11.8. Insilico Medicine
11.8.1. Company Overview
11.8.2. Key Executives
11.8.3. Footprint & Employee Strength
11.8.4. Product Offerings
11.8.5. Financials
11.8.6. Key Company Developments
11.9. Benevolentai
11.9.1. Company Overview
11.9.2. Key Executives
11.9.3. Footprint & Employee Strength
11.9.4. Product Offerings
11.9.5. Financials
11.9.6. Key Company Developments
11.10. Exscientia
11.10.1. Company Overview
11.10.2. Key Executives
11.10.3. Footprint & Employee Strength
11.10.4. Product Offerings
11.10.5. Financials
11.10.6. Key Company Developments
12. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
- Published Date: Feb - 2021
- Report Format: Excel/PPT
- Report Code: ICTHM01A-00-0719
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Artificial Intelligence (AI) in Drug Discovery Market by Offering, By Technology, By Application, By End User and By Region – Global Opportunities & Forecast, 2020-2027
$ 4,499.00 – $ 6,649.00
Why GMI Research
